lobbying_activities: 3599447

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3599447	9340f9a2-c55c-41c7-80d2-d4dda6fb4f34	Q2	CROSSROADS STRATEGIES, LLC	400531586	TAKEDA PHARMACEUTICALS AMERICA, INC.	2025	second_quarter	TAX	Issues related to tax reform; R&D tax credit; orphan drug tax credit; Inflation Reduction Act of 2022 (P.L.117-169) implementation; Section 899; H.R.1, One Big Beautiful Bill Act.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2025-07-19T12:57:36-04:00